Short-term clinical outcomes of acute treatment of childhood asthma

Current Opinion in Allergy and Clinical Immunology

Volumn 5, Issue 3, 2005, Pages 241-246

  Benito Fernández, Javier ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Acute asthma; Asthma therapy; Clinical outcome; Emergency room; Follow up; Symptom persistence

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; STEROID;

ACUTE DISEASE; AEROSOL; ASTHMA; CHILD; CHILDHOOD DISEASE; DISEASE CONTROL; DISEASE EXACERBATION; EMERGENCY TREATMENT; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; METERED DOSE INHALER; MORBIDITY; MORTALITY; NEBULIZATION; OUTPATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RELAPSE; REVIEW; SELF CARE; SIDE EFFECT; TREATMENT OUTCOME;

EID: 18844394807     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.all.0000168788.97453.02     Document Type: Review

References (42)

1. Global Initiative for asthma (GINA) reports. Global strategy for asthma management and prevention. NIH Publication No. 02-3659 issued January 1995. Updated 2004 from the 2003 document. http://www.ginasthma.com. This is an important reference document for all professionals involved in the management of asthma at any health care level. It is probably the most complete consensus report currently available on all aspects of asthma (epidemiology, pathophysiology, diagnosis, assessment of severity, treatment of acute exacerbations, maintenance treatment, follow-up plans, etc.).
2. Burney PGJ, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86. BMJ 1990; 300:1306-1310.
3. Wennergren G, Kristjánsson S, Strannegard IL. Decrease in hospitalization for treatment of childhood asthma with increased use of antiiflamatory treatment, despite an increase in the prevalence of asthma. J Allergy Clin Immunol 1996; 97:742-748.
4. Benito J, Bayon JL, Montiano J, et al. Time trends in acute childhood asthma in Basque Country, Spain. Pediatr Pulmonol 1995; 20:184-188.
5. Canny GJ, Reisman J, Healy R, et al. Acute asthma: observations regarding the management of a pediatric emergency room. Pediatrics 1989; 83:507-512.
6. Benito Fernandez J, Mintegui Raso S, Sanchez Echaniz J, et al. Recent changes in emergency room visits and hospitalization for asthma in childhood [in Spanish]. An Esp Pediatr 1998; 49:577-581.
7. Russo MJ, McConnochie KM, McBride JT, et al. Increase in admission threshold explains stable asthma hospitalization rates. Pediatrics 1999; 104:454-462.
8. Benito-Fernández J, Onis-González E, Álvarez-Pitti J, et al. Factors associated with short-term clinical outcomes after acute treatment of asthma in a pediatric emergency department. Pediatr Pulmonol 2004; 38:123-128. In this prospective cohort study, the short-term outcome of children with asthma attending the emergency department is worse than expected, particularly in children under 2 years of age. However, in children older than 2 years, an adequate medical follow-up and the use of inhaled corticosteroids in the maintenance treatment of asthma favored a prompt recovery.
9. Stevens MW, Gorelick MH. Short-term outcomes after acute treatment of pediatric asthma. Pediatrics 2001; 107:1357-1362.
10. British guideline on the management of asthma. Thorax 2003; 58 (Suppl 1): i1-i94.
11. Benito Fernandez J, Mintegui Raso S, Sanchez Echaniz J, et al. Efficacy of early administration of nebulized ipratropium bromide in children with asthmatic crisis [in Spanish]. An Esp Pediatr 2000; 53:217-222.
12. Plotnick LH, Ducharme FM. Acute asthma in children and adolescents: should inhaled anticholinergics be added to beta(2)-agonists? Am J Respir Med 2003; 2:109-115.
13. Emerman CL, Cydulka RK, Crain EF, et al. Prospective multicenter study of relapse after treatment for acute asthma among children presenting to the emergency department. J Pediatr 2001; 138:318-324.
14. Gorelick MH, Brousseau DC, Stevens MW. Validity and responsiveness of a brief, asthma-specific quality-of-life instrument in children with acute asthma. Ann Allergy Asthma Immunol 2004; 92:47-51. This study demonstrates the validity and responsiveness of a disease-specific quality of life instrument - the Integrated Therapeutic Group Child Asthma Short Form (ITG-CASF) - in children treated in an emergency department for acute asthma. This tool may be a useful outcome measure in evaluating emergency department treatment.
15. Gorelick MH, Scribano PV, Stevens MW, Schultz TR. Construct validity and responsiveness of the Child Health Questionnaire in children with acute asthma. Ann Allergy Asthma Immunol 2003; 90:622-628.
16. Schaubel D, Johansen H, Mao Y, et al. Risk of preschool asthma: incidence, hospitalization, recurrence, and readmission probability. J Asthma 1996; 33:97-103.
17. Rachelefsky G. Treating exacerbations of asthma in children: the role of systemic corticosteroids. Pediatrics 2003; 112:382-397.
18. Rowe BH, Edmonds ML, Spooner CH, et al. Corticosteroid therapy for acute asthma. Respir Med 2004; 98:275-284. Interesting review of publications contained in the Cochrane Library of the role of systemic and inhaled corticosteroids in the treatment of asthma. It is suggested that an emergency department visit is a great opportunity to review the patient's asthma maintenance treatment, and there is some evidence to support the recommendation of the combined use of systemic and inhaled steroids at the time of discharge.
19. Rowe BH, Spooner CH, Ducharme FM, et al. Corticosteroids for preventing relapse following acute exacerbations of asthma [Cochrane review]. The Cochrane Library 2004; issue 4. Chichester, UK: John Wiley & Sons. This systematic review concludes that a short course (5-10 days) of corticosteroids (oral or intramuscular) following assessment for an acute exacerbation of asthma significantly reduces the number of relapses to additional care and decreases β-agonist use without an apparent increase in side effects.
20. Hendeles L. Selecting a systemic corticosteroid for acute asthma in young children. J Pediatr 2003; 142:340-344.
21. Hendeles L, Sherman J. Are inhaled corticosteroids effective for acute exacerbations of asthma in children? J Pediatr 2003; 142:326-333.
22. Nakanishi AK, Klasner AK, Rubin BK. A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. Chest 2003; 124:790-794.
23. Edmonds ML, Camargo CA Jr, Pollack CV Jr, Rowe BH. Early use of inhaled corticosteroids in the emergency department of acute asthma [Cochrane review]. The Cochrane Library 2004; issue 4. Chichester, U K: John Wiley & Sons.
24. Edmonds ML, Camargo CA Jr, Pollack CV Jr, Rowe BH. The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: a meta-analysis. Ann Emerg Med 2002; 40:145-154.
25. FitzGerald JM, Becker A, Sears MR, et al. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax 2004; 59:550-556. This study indicates that doubling the maintenance dose of inhaled corticosteroid to improve the pattern of asthma exacerbation is questionable.
26. Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the dose of a inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet 2004; 363:271-275. According to this study there is little evidence to support the widely recommended intervention of doubling the dose of inhaled corticosteroid when asthma control starts to deteriorate.
27. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics 2001; 107:706-711.
28. Berger WE, Shapiro GG. The use of inhaled corticosteroids for persistent asthma in infants and young children. Ann Allergy Asthma Immunol 2004; 92:387-399. A review of relevant articles of inhaled corticosteroid use in pediatric asthma consistently shows that inhaled steroid therapy is the most favorable treatment option with regard to safety and efficacy in infants and young children with persistent asthma. However, because budesonide inhalation suspension as a nebulized formulation is the only corticosteroid available in the United States, this agent has been extensively studied in children younger than 5 years.
29. 2-agonists, teophylline, cromolyn sodium, nedocromil, or any combination of those. No studies have examined the long-term impact of regular inhaled corticosteroids on lung function in children 5 years old and younger.
30. Castro-Rodriguez JA, Rodrigo GJ. Beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J Pediatr 2004; 145:172-177. In the emergency department setting, the use of a MDI with spacer was more effective in terms of decreasing hospitalization and improving clinical score than the use of a nebulizer in the delivery of β-agonists to children under 5 years of age.
31. Powell CVE, Maskell GR, Marks MK, et al. Successful implementation of spacer treatment guideline for acute asthma. Arch Dis Child 2001; 84:142-146.
32. Delgado A, Chou KJ, Silver EJ, Crain EF. Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. Arch Pediatr Adolesc Med 2003; 157:76-80.
33. Benito-Fernandez J, Gonzalez-Balenciaga M, Capape-Zache S, et al. Salbutamol via metered-dose inhaler with spacer versus nebulization for acute treatment of pediatric asthma in the emergency department. Pediatr Emerg Care 2004; 20:656-659. This study examined the effectiveness of salbutamol delivered via a MDI with spacer versus a nebulizer for acute asthma treatment in the pediatric emergency department. It is shown that the numbers of children who required a stay in the observation unit, admission to the hospital, or returned for medical care were similar for both modes of salbutamol administration.
34. Kamps AW, Van Ewijk B, Roorda RJ, Brand PL. Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr Pulmonol 2000; 29:39-42.
35. Sekhsaria S, Alam M, Sait T, et al. Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5. J Asthma 2004; 41:575-582, Although this is a retrospective study of a small number of patients, it is one of the few reports examining the efficacy and safety of a combination of fluticasone propionate and salmeterol in children under 5 years of age. This study shows that combination therapy is highly efficacious and safe for children under the age of 5.
36. 2-agonists for the maintenance treatment of asthma.
37. Berg J, Wahlgren DR, Hofstetter CR, et al. Latino children with asthma: rates and risks for medical care utilization. J Asthma 2004; 41:147-157.
38. Butz AM, Riekert KA, Eggleston P, et al. Factors associated with preventive asthma care in inner-city children. Clin Pediatr (Phila) 2004; 43:709-719. This interesting cross-sectional study in a sample of inner-city children with moderate to severe persistent asthma, caregiver's level of asthma burden (emergency department visits and school absences) were more important factors than the child's actual level of asthma symptoms in the caregiver's decision to make and keep preventive care appointments.
39. Smith SR, Jaffe DM, Petty M, et al. Recruitment into a long-term pediatric asthma study during emergency department visits. J Asthma 2004; 41:477-484.
40. Fisher EB, Strunk RC, Sussman LK, et al. Community organization to reduce the need for acute care for asthma among African American children in low-income neighborhoods: the Neighborhood Asthma Coalition. Pediatrics 2004; 114:116-123.
41. Kennedy S, Stone A, Rachelefsky G. Factors associated with emergency department use in asthma: acute care interventions improving chronic disease outcomes. Ann Allergy Asthma Immunol 2003; 90:45-50.
42. Zorc JJ, Scarfone RJ, Li Y, et al. Scheduled follow-up after a pediatric emergency department visit for asthma: a randomized trial. Pediatrics 2003; 111:495-502.